Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.
- 1 December 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (6) , 2746-2755
- https://doi.org/10.1172/jci116892
Abstract
Homozygous plasminogen activator inhibitor-1 (PAI-1)-deficient (PAI-1-/-) mice were generated by homologous recombination in D3 embryonic stem cells. Deletion of the genomic sequences encompassing the transcription initiation site and the entire coding regions of murine PAI-1 was demonstrated by Southern blot analysis. A 3.0-kb PAI-1-specific mRNA was identified by Northern blot analysis in liver from PAI-1 wild type (PAI-1+/+) but not from PAI-1-/- mice. Plasma PAI-1 levels, measured 2-4 h after endotoxin (2.0 mg/kg) injection were 63 +/- 2 ng/ml, 30 +/- 10 ng/ml, and undetectable (< 2 ng/ml) in PAI-1+/+, heterozygous (PAI-1+/-) and PAI-1-/- mice, respectively (mean +/- SEM, n = 4-11). PAI-1-specific immunoreactivity was demonstrable in kidneys of PAI-1+/+ but not of PAI-1-/- mice. SDS-gel electrophoresis of plasma incubated with 125I-labeled recombinant human tissue-type plasminogen activator revealed an approximately 115,000-M(r) component with plasma from endotoxin-stimulated (0.5 mg/kg) PAI-1+/+ but not from PAI-1-/- mice, which could be precipitated with a polyclonal anti-PAI-1 antiserum. PAI-1-/- mice were viable, produced similar sizes of litters as PAI-1+/+ mice, and showed no apparent macroscopic or microscopic histological abnormalities.Keywords
This publication has 24 references indexed in Scilit:
- Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.Journal of Clinical Investigation, 1993
- PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND TYPE-2 IN HUMAN TROPHOBLASTS - PAI-1 IS AN IMMUNOCYTOCHEMICAL MARKER OF INVADING TROPHOBLASTS1989
- Type 1 plasminogen activator inhibitor.1989
- Suppression of Ovulation Rate by Antibodies to Tissue-Type Plasminogen Activator and α2-Antiplasmin*Endocrinology, 1989
- Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markersNucleic Acids Research, 1989
- Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genesNature, 1988
- Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.Journal of Biological Chemistry, 1985
- The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardiumDevelopment, 1985
- Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human PlasmaThrombosis and Haemostasis, 1984
- Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endodermCell, 1976